Welcome to this webinar with Dr. Nicolai J. Wewer Albrechtsen, Associate Professor at Novo Nordisk Foundation Center for Protein Research, University of Copenhagen.
During the webinar Dr. Wewer Albrechtsen will discuss current data for how hyperglucagonemia may or may not mark a disrupted liver-alpha cell axis. After Dr. Wewer Albrechtsen’s presentation attendees will have the possibility to ask questions.
Date: Thursday December 10, 2020
Time: 16:00 – 17:00 CET
|Dr. Wewer Albrechtsen earned his MD at the University of Copenhagen in 2014. Since 2011, he has been working on gastrointestinal hormones and in particular glucagon biology. In recent years,|
Dr. Wewer Albrechtsen has initiated his own scientific group that investigates the actions of glucagon in dysmetabolic conditions such as diabetes, obesity and NAFLD with the use of state-of art technologies including mass-spectrometry. The group currently focuses on exploring a new physiological term known as glucagon resistance, identified in mice and humans with NAFLD.